
Blasts in Peripheral Blood: Differential Diagnostics
A clinical case of an 86-year-old patient with 17% blasts in the blood: morphological criteria for assessing immature cells and differential diagnostics in a blood smear.
Tag

A clinical case of an 86-year-old patient with 17% blasts in the blood: morphological criteria for assessing immature cells and differential diagnostics in a blood smear.

A case of acute T-lymphoblastic leukemia: blast morphology in a blood smear, thrombocytopenia, and immunophenotyping data in an 18-year-old patient.

Clinical case of pancytopenia in an 82-year-old female patient: evaluation of blast morphology with cytoplasmic vacuolization in bone marrow aspirate.

Clinical case of acute myeloid leukemia in a child with Down syndrome: hyperleukocytosis, blast morphology with Auer rods, and cytochemistry.

A clinical case of differential diagnosis between AML and MDS in a 32-year-old patient with pancytopenia: smear morphology, blast count, and flow cytometry.

A 59-year-old female patient presents with leukopenia and anemia. This case study examines the morphology of large blasts with basophilic cytoplasm in the bone marrow during acute leukemia.

Morphological features of acute myelomonocytic leukemia (AML M4): diagnostic criteria for differentiating monoblasts and promonocytes in a blood smear.

Morphology of myeloblasts with pseudo-Chediak-Higashi inclusions in bone marrow aspirate in acute myeloid leukemia with maturation (AML M2) in a child.

Criteria for differential diagnosis of blast cells and mature lymphocytes in a blood smear: chromatin structure, nucleoli, and cytoplasm for clinical laboratory diagnostics specialists.

Atypical blast forms in acute myeloid leukemia: Auer rods, hand-mirror cells, cup-like morphology, and flower-shaped nuclei in a blood smear.

Evaluation of myeloperoxidase activity using benzidine in bone marrow aspirate from acute myelomonocytic leukemia. Cytochemical verification of blasts.

Clinical case of megakaryocytic dysplasia in bone marrow: micromegakaryocytes, hypolobulated nuclei, and 6% myeloblasts in a patient with splenomegaly.